These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29332964)

  • 1. Relapse of polymyalgia rheumatica after a fall.
    Manzo C; Natale M
    Reumatologia; 2017; 55(5):251-255. PubMed ID: 29332964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
    Cleuziou C; Binard A; De Bandt M; Berthelot JM; Saraux A
    J Rheumatol; 2012 Feb; 39(2):310-3. PubMed ID: 22174199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable Rates of Glucocorticoid-Associated Adverse Events in Patients With Polymyalgia Rheumatica and Comorbidities in the General Population.
    Shbeeb I; Challah D; Raheel S; Crowson CS; Matteson EL
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):643-647. PubMed ID: 28704600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
    Sulli A; Montecucco CM; Caporali R; Cavagna L; Montagna P; Capellino S; Fazzuoli L; Seriolo B; Alessandro C; Secchi ME; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():307-14. PubMed ID: 16855158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
    Lally L; Forbess L; Hatzis C; Spiera R
    Arthritis Rheumatol; 2016 Oct; 68(10):2550-4. PubMed ID: 27159185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
    J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
    Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
    Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    Gonzalez-Gay MA; Garcia-Porrua C; Salvarani C; Olivieri I; Hunder GG
    J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone.
    Benucci M; Olivito B; Manfredi M; Meacci F; Infantino M; Li Gobbi F; Sarzi-Puttini P; Marcassa C; Atzeni F
    Eur Rev Med Pharmacol Sci; 2015; 19(5):745-51. PubMed ID: 25807425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of the association with CC chemokine receptor 5 polymorphism in polymyalgia rheumatica.
    Salvarani C; Boiardi L; Timms JM; Silvestri T; Ranzi A; Macchioni PL; Pulsatelli L; di Giovine FS
    Clin Exp Rheumatol; 2000; 18(5):591-5. PubMed ID: 11072599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Relapse and/or Prolonged Glucocorticoid Therapy in Polymyalgia Rheumatica: Multicenter Study in 185 Patients.
    Vinicki JP; Gut O; Maliandi MDR; Velasco Zamora JL; Linarez M; Cusa MA; Got J; Spinetto MA; Estevez AJ; Brigante A; Curti AC; Costi AC; Cavallasca J
    J Clin Rheumatol; 2024 Jan; 30(1):e34-e38. PubMed ID: 37185203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the polymyalgia rheumatica activity score in primary care practice.
    Binard A; Lefebvre B; De Bandt M; Berthelot JM; Saraux A;
    Ann Rheum Dis; 2009 Apr; 68(4):541-5. PubMed ID: 18477738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients.
    Quartuccio L; Gregoraci G; Isola M; De Vita S
    Geriatr Gerontol Int; 2018 Sep; 18(9):1410-1414. PubMed ID: 29978586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Opin Pharmacother; 2018 Aug; 19(11):1235-1244. PubMed ID: 30040482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse in a population based cohort of patients with polymyalgia rheumatica.
    Kremers HM; Reinalda MS; Crowson CS; Zinsmeister AR; Hunder GG; Gabriel SE
    J Rheumatol; 2005 Jan; 32(1):65-73. PubMed ID: 15630727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Shoulder Ultrasonography Is Not a Predictive Marker of Response to Glucocorticoids in Patients with Polymyalgia Rheumatica: A 12-month Followup Study.
    Miceli MC; Zoli A; Peluso G; Bosello S; Gremese E; Ferraccioli G
    J Rheumatol; 2017 Feb; 44(2):241-247. PubMed ID: 27980012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Boiardi L; Macchioni P; Rossi F; Tartoni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
    Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.